Principal investigator, CADENZA trial
Appears in 1 story
Last updated May 28, 2026
As of May 2026: Chief of Myeloid Malignancies, MD Anderson Cancer Center
The FDA approved AbbVie's Decnupaz on May 27 for blastic plasmacytoid dendritic cell neoplasm, an aggressive blood cancer. It strikes an estimated few hundred Americans a year. It's the second drug ever approved for the disease and the first doctors can start in an outpatient clinic.
Updated May 28
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
